2196.HK · FOSUN PHARMA
Hong Kong · RS rating 60 · As of 2026-10-14
| Price | 17.22 HKD |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 67 / 66 / 35 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 14 / 29 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -17.9% |
| Distance from 52-week high | +35.1% |
| Market cap (USD) | $6.1B |